The twenty-first century has brought humanity huge technological development but also many of the problems associated with interference in the natural environment. One of these problems is the bacterial antibiotic resistance caused by excessive use of antibiotics. Exploring the potential of natural antimicrobial peptides is very important in combating multi-drug resistance of microorganisms.
Human β defensin-2 (HBD2) is a cysteine-rich cationic, small (2-6 kDa), antimicrobial peptide that is considered to be important antibiotic-like effectors of innate immunity [1]. HBD2 is produced by epithelial cells inter alia in response to contact with microorganisms. It exhibits potent antimicrobial activity against gram-negative bacteria and Candida but was less effective against gram-positive Staphylococcus aureus [2]. The mechanism by which microorganisms are killed by defensins is not understood completly but there is a huge potential and hope in these small peptides to combat multi-drug resistance microorganisms.